April 14, 2000 - Volume 14 - Issue 6 - Contributor Index

Alphabetical Search
I
Q
U
X
Author:
Ahmad, Ali
Author:
Ahmad, Rasheed
Author:
Alvarez, Camilo

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

Puig, Teresa; Pérez-Olmeda, Mayte; Rubio, Amalia; More

AIDS . 14(6):727-732, April 14, 2000.

Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs

Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.; More

AIDS . 14(6):659-669, April 14, 2000.

Author:
Barcova, Maria
Author:
Becker, Stephen

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection

Eron, Joseph J.; Yetzer, Ellen S.; Ruane, Peter J.; More

AIDS . 14(6):671-681, April 14, 2000.

Author:
Briones, Carlos

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

Puig, Teresa; Pérez-Olmeda, Mayte; Rubio, Amalia; More

AIDS . 14(6):727-732, April 14, 2000.

Author:
Brown, Donald
Author:
Cervia, Joseph
Author:
Chmiel, Joan S.

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

Puig, Teresa; Pérez-Olmeda, Mayte; Rubio, Amalia; More

AIDS . 14(6):727-732, April 14, 2000.

Author:
Dandekar, Satya
Author:
Dash, Bipin C.
Author:
Davidovich, Udi
Author:
Day, Roger
Author:
de Wolf, Frank

Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs

Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.; More

AIDS . 14(6):659-669, April 14, 2000.

Author:
Detels, Roger
Author:
Doherty, Meg C.
Author:
Eno, Laura T.
Author:
Eron, Joseph J.

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection

Eron, Joseph J.; Yetzer, Ellen S.; Ruane, Peter J.; More

AIDS . 14(6):671-681, April 14, 2000.

Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs

Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.; More

AIDS . 14(6):659-669, April 14, 2000.

Author:
Fischer, Marek

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection

Eron, Joseph J.; Yetzer, Ellen S.; Ruane, Peter J.; More

AIDS . 14(6):671-681, April 14, 2000.

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

Puig, Teresa; Pérez-Olmeda, Mayte; Rubio, Amalia; More

AIDS . 14(6):727-732, April 14, 2000.

Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs

Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.; More

AIDS . 14(6):659-669, April 14, 2000.

Author:
Gange, Stephen
Author:
Ghani, Azra C.

Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs

Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.; More

AIDS . 14(6):659-669, April 14, 2000.

Author:
Giunta, Yvonne

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

Puig, Teresa; Pérez-Olmeda, Mayte; Rubio, Amalia; More

AIDS . 14(6):727-732, April 14, 2000.

Author:
Goudsmit, Jaap

Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs

Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.; More

AIDS . 14(6):659-669, April 14, 2000.

Author:
Graedner, Irina
Author:
Grosser, Stella
Author:
Haller, Ivan
Author:
Harrer, Ellen
Author:
Harrer, Thomas
Author:
Joos, Beda
Author:
Lal, Renu B.
Author:
Lamb, Karan

Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs

Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.; More

AIDS . 14(6):659-669, April 14, 2000.

Author:
Leal, Manolo

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

Puig, Teresa; Pérez-Olmeda, Mayte; Rubio, Amalia; More

AIDS . 14(6):727-732, April 14, 2000.

Author:
Makumbi, Fred
Author:
Menezes, José
Author:
Morris, Martina
Author:
Muñoz, Alvaro
Author:
Nail, Clint D.
Author:
Noel, Gary J.
Author:
Nokta, Mostafa
Author:
Opravil, Milos
Author:
Ott, Peter

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

Puig, Teresa; Pérez-Olmeda, Mayte; Rubio, Amalia; More

AIDS . 14(6):727-732, April 14, 2000.

Author:
Prins, Jan M.

Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs

Fraser, Christophe; Ferguson, Neil M.; Ghani, Azra C.; More

AIDS . 14(6):659-669, April 14, 2000.

Author:
Puig, Teresa

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

Puig, Teresa; Pérez-Olmeda, Mayte; Rubio, Amalia; More

AIDS . 14(6):727-732, April 14, 2000.

Author:
Rayfield, Mark
Author:
Reay, Elizabeth
Author:
Ruane, Peter J.

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection

Eron, Joseph J.; Yetzer, Ellen S.; Ruane, Peter J.; More

AIDS . 14(6):671-681, April 14, 2000.

Author:
Rubio, Amalia

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

Puig, Teresa; Pérez-Olmeda, Mayte; Rubio, Amalia; More

AIDS . 14(6):727-732, April 14, 2000.